Importance of Investing in R&D and Quality for...

Vineet Dwivedi, Global Head, Alcon Global Services

In an interaction with India Pharma Outlook, Vineet Dwivedi, Global Head, Alcon Global Services, discusses how employee engagement in the pharmaceutical industry has evolved to focus on well-being, flexibility, diversity, and career growth.

Strategic finance for pharmaceutical innovation...

Melagiri Sridhar, Chief Financial Officer, Bafna Pharmaceuticals

Melagiri Sridhar, Chief Financial Officer, Bafna Pharmaceuticals in a recent interaction with India Pharma Outlook, shared his views on how CFOs in the pharmaceutical industry should balance investments in advanced stability-enhancing technologies...

How Organic Synthesis is Accelerating Drug...

Ajay Bhardwaj, CEO, Anthem Biosciences Private Limited

In an interaction with India Pharma Outlook, Ajay Bhardwaj, CEO, Anthem Biosciences Private Limited discusses about the role of organic synthesis in accelerating drug discovery, highlighted the significance of diligence at an early stage, AI-driven..

Gender Gap in Healthcare: Why Women's Health...

Vivek Soares, Country Lead, India and South Asia, Organon

In an interaction with India Pharma Outlook, Vivek Soares, Country Lead, India and South Asia, Organon, discusses the progress and gaps in women’s healthcare, emphasizing the need for gender-specific research, improved access, policy reforms...

Enhancing Clinical Trial Supply Chain...

Sanjay Vyas, President, Global Head Safety Services and Clinical Logistics and Managing Director...

In an interaction with India Pharma Outlook, Sanjay Vyas, President, Global Head of Safety Services &Clinical Logistics, and Managing Director, India at Parexel, discusses ways in which Indian pharma firmsstrengthen clinical trial supply chains

Balancing Innovation and Affordability in...

Rajiv Gupta, Country Business Leader (Healthcare Business), 3M India

Rajiv Gupta, Country Business Leader (Healthcare Business) at 3M India Limited in an exclusive interaction with India Pharma Outlook, discusses the growth of India's medical device market, noting that 70 percent of devices are still imported...

on the deck


Most Viewed

Editor's Guest


© 2025 India Pharma Outlook. All Rights Reserved.